questionsmedicales.fr
Phénomènes physiologiques de l'appareil locomoteur et du système nerveux
Phénomènes physiologiques du système nerveux
Transmission synaptique
Transmission synaptique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Transmission synaptique : Questions médicales les plus fréquentes",
"headline": "Transmission synaptique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Transmission synaptique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-29",
"dateModified": "2025-02-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Transmission synaptique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiologiques du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D009424",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiologiques du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009424",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G11.561"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Potentiels synaptiques",
"alternateName": "Synaptic Potentials",
"url": "https://questionsmedicales.fr/mesh/D055366",
"about": {
"@type": "MedicalCondition",
"name": "Potentiels synaptiques",
"code": {
"@type": "MedicalCode",
"code": "D055366",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G11.561.830.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Potentiels post-synaptiques excitateurs",
"alternateName": "Excitatory Postsynaptic Potentials",
"url": "https://questionsmedicales.fr/mesh/D019706",
"about": {
"@type": "MedicalCondition",
"name": "Potentiels post-synaptiques excitateurs",
"code": {
"@type": "MedicalCode",
"code": "D019706",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G11.561.830.750.199"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Potentiels post-synaptiques inhibiteurs",
"alternateName": "Inhibitory Postsynaptic Potentials",
"url": "https://questionsmedicales.fr/mesh/D053444",
"about": {
"@type": "MedicalCondition",
"name": "Potentiels post-synaptiques inhibiteurs",
"code": {
"@type": "MedicalCode",
"code": "D053444",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G11.561.830.750.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Potentiels post-synaptiques miniatures",
"alternateName": "Miniature Postsynaptic Potentials",
"url": "https://questionsmedicales.fr/mesh/D055369",
"about": {
"@type": "MedicalCondition",
"name": "Potentiels post-synaptiques miniatures",
"code": {
"@type": "MedicalCode",
"code": "D055369",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G11.561.830.750.560"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sommation des potentiels post-synaptiques",
"alternateName": "Postsynaptic Potential Summation",
"url": "https://questionsmedicales.fr/mesh/D059227",
"about": {
"@type": "MedicalCondition",
"name": "Sommation des potentiels post-synaptiques",
"code": {
"@type": "MedicalCode",
"code": "D059227",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G11.561.830.750.780"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Transmission synaptique",
"alternateName": "Synaptic Transmission",
"code": {
"@type": "MedicalCode",
"code": "D009435",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dietmar Schmitz",
"url": "https://questionsmedicales.fr/author/Dietmar%20Schmitz",
"affiliation": {
"@type": "Organization",
"name": "Neuroscience Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. dietmar.schmitz@charite.de."
}
},
{
"@type": "Person",
"name": "Christian Lüscher",
"url": "https://questionsmedicales.fr/author/Christian%20L%C3%BCscher",
"affiliation": {
"@type": "Organization",
"name": "Department of Basic Neurosciences, Medical Faculty, University of Geneva, CH-1211 Geneva, Switzerland. christian.luscher@unige.ch."
}
},
{
"@type": "Person",
"name": "James E Rothman",
"url": "https://questionsmedicales.fr/author/James%20E%20Rothman",
"affiliation": {
"@type": "Organization",
"name": "Nanobiology Institute and Department of Cell Biology, Yale University, New Haven, CT, USA."
}
},
{
"@type": "Person",
"name": "Kirill Grushin",
"url": "https://questionsmedicales.fr/author/Kirill%20Grushin",
"affiliation": {
"@type": "Organization",
"name": "Nanobiology Institute and Department of Cell Biology, Yale University, New Haven, CT, USA."
}
},
{
"@type": "Person",
"name": "Manindra Bera",
"url": "https://questionsmedicales.fr/author/Manindra%20Bera",
"affiliation": {
"@type": "Organization",
"name": "Nanobiology Institute and Department of Cell Biology, Yale University, New Haven, CT, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Complement factors D and C3 cross-sectionally associate with arterial stiffness, but not independently of metabolic risk factors: The Maastricht Study.",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35881455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HJH.0000000000003237"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37105991",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-37988-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37453328",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cyto.2023.156295"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel fasting regimen revealed protein reservation and complement C3 down-regulation after 14-day's continual dietary deprivation.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37484967",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1150547"
}
},
{
"@type": "ScholarlyArticle",
"name": "Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.",
"datePublished": "2023-02-15",
"url": "https://questionsmedicales.fr/article/36805858",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.imbio.2023.152351"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques de l'appareil locomoteur et du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D055687"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009424"
},
{
"@type": "ListItem",
"position": 4,
"name": "Transmission synaptique",
"item": "https://questionsmedicales.fr/mesh/D009435"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Transmission synaptique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Transmission synaptique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Transmission synaptique",
"description": "Comment diagnostiquer un dysfonctionnement synaptique ?\nQuels examens sont utilisés pour évaluer la transmission synaptique ?\nQuels symptômes indiquent un problème de transmission synaptique ?\nPeut-on mesurer la transmission synaptique directement ?\nQuels marqueurs biologiques sont associés à la transmission synaptique ?",
"url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+C3&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Transmission synaptique",
"description": "Quels symptômes sont liés à une transmission synaptique altérée ?\nComment la dépression affecte-t-elle la transmission synaptique ?\nLes troubles de l'humeur sont-ils liés à la transmission synaptique ?\nQuels signes neurologiques peuvent indiquer un problème synaptique ?\nLa fatigue chronique est-elle liée à la transmission synaptique ?",
"url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+C3&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Transmission synaptique",
"description": "Comment prévenir les troubles de la transmission synaptique ?\nLe stress affecte-t-il la transmission synaptique ?\nL'exercice physique influence-t-il la transmission synaptique ?\nLes habitudes de sommeil affectent-elles la transmission synaptique ?\nLa méditation peut-elle améliorer la transmission synaptique ?",
"url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+C3&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Transmission synaptique",
"description": "Quels traitements existent pour améliorer la transmission synaptique ?\nLa thérapie cognitive peut-elle aider la transmission synaptique ?\nLes suppléments alimentaires influencent-ils la transmission synaptique ?\nComment la stimulation cérébrale affecte-t-elle la transmission synaptique ?\nLes thérapies comportementales aident-elles la transmission synaptique ?",
"url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+C3&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Transmission synaptique",
"description": "Quelles complications peuvent résulter d'une transmission synaptique altérée ?\nLes maladies neurodégénératives affectent-elles la transmission synaptique ?\nComment les troubles de l'apprentissage sont-ils liés à la transmission synaptique ?\nLes troubles psychotiques sont-ils liés à la transmission synaptique ?\nLa schizophrénie affecte-t-elle la transmission synaptique ?",
"url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+C3&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Transmission synaptique",
"description": "Quels facteurs de risque influencent la transmission synaptique ?\nL'alimentation joue-t-elle un rôle dans la transmission synaptique ?\nLe tabagisme affecte-t-il la transmission synaptique ?\nLes maladies chroniques influencent-elles la transmission synaptique ?\nLe manque d'activité physique est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D009435?mesh_terms=Complement+C3&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un dysfonctionnement synaptique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests électrophysiologiques et des imageries cérébrales peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer la transmission synaptique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM fonctionnelle et l'électroencéphalogramme (EEG) sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de transmission synaptique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la mémoire, des convulsions ou des changements de comportement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer la transmission synaptique directement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la microscopie à fluorescence permettent d'observer la transmission."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés à la transmission synaptique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protéines comme la synaptophysine peuvent servir de marqueurs pour la synapse."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une transmission synaptique altérée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes incluent des troubles cognitifs, des spasmes musculaires et des douleurs."
}
},
{
"@type": "Question",
"name": "Comment la dépression affecte-t-elle la transmission synaptique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dépression peut réduire la plasticité synaptique, affectant la communication neuronale."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés à la transmission synaptique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres dans les neurotransmetteurs peuvent provoquer des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Quels signes neurologiques peuvent indiquer un problème synaptique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent des tremblements, des troubles de la coordination et des réflexes anormaux."
}
},
{
"@type": "Question",
"name": "La fatigue chronique est-elle liée à la transmission synaptique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans la transmission synaptique peuvent contribuer à la fatigue chronique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la transmission synaptique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il la transmission synaptique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut altérer la transmission synaptique et la plasticité."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il la transmission synaptique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier favorise la santé neuronale et la transmission synaptique."
}
},
{
"@type": "Question",
"name": "Les habitudes de sommeil affectent-elles la transmission synaptique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un sommeil de qualité est crucial pour la régénération synaptique et cognitive."
}
},
{
"@type": "Question",
"name": "La méditation peut-elle améliorer la transmission synaptique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la méditation peut augmenter la plasticité synaptique et réduire le stress."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour améliorer la transmission synaptique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les antidépresseurs et les nootropiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La thérapie cognitive peut-elle aider la transmission synaptique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut améliorer la plasticité synaptique et la fonction cognitive."
}
},
{
"@type": "Question",
"name": "Les suppléments alimentaires influencent-ils la transmission synaptique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments comme les oméga-3 peuvent favoriser la santé synaptique."
}
},
{
"@type": "Question",
"name": "Comment la stimulation cérébrale affecte-t-elle la transmission synaptique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La stimulation cérébrale peut renforcer les connexions synaptiques et améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Les thérapies comportementales aident-elles la transmission synaptique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent améliorer les interactions neuronales et la plasticité synaptique."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une transmission synaptique altérée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles neurologiques, des troubles de l'humeur et des crises."
}
},
{
"@type": "Question",
"name": "Les maladies neurodégénératives affectent-elles la transmission synaptique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme Alzheimer altèrent gravement la transmission synaptique."
}
},
{
"@type": "Question",
"name": "Comment les troubles de l'apprentissage sont-ils liés à la transmission synaptique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans la transmission synaptique peuvent entraîner des difficultés d'apprentissage."
}
},
{
"@type": "Question",
"name": "Les troubles psychotiques sont-ils liés à la transmission synaptique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres dans les neurotransmetteurs peuvent contribuer aux troubles psychotiques."
}
},
{
"@type": "Question",
"name": "La schizophrénie affecte-t-elle la transmission synaptique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la schizophrénie est associée à des dysfonctionnements dans la transmission synaptique."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent la transmission synaptique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, le stress et la génétique peuvent influencer la transmission."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la transmission synaptique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments favorise une transmission synaptique saine."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il la transmission synaptique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer la fonction synaptique et augmenter le risque de troubles."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles la transmission synaptique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent affecter la transmission synaptique."
}
},
{
"@type": "Question",
"name": "Le manque d'activité physique est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inactivité physique peut nuire à la santé synaptique et cognitive."
}
}
]
}
]
}
Arterial stiffness predicts cardiovascular outcomes. The complement system, particularly the alternative complement pathway, has been implicated in cardiovascular diseases. We herein investigated the ...
In 3019 population-based participants (51.9% men, 60.1 ± 8.2 years, 27.7% type 2 diabetes [T2D], oversampled]), we measured carotid-femoral pulse wave velocity (cfPWV), carotid distensibility coeffici...
Per SD higher factors D and C3, cfPWV was 0.41 m/s [95% confidence interval: 0.34; 0.49] and 0.33 m/s [0.25; 0.41] greater, respectively. These associations were substantially attenuated when adjusted...
The strong association of plasma factors D and C3 with arterial stiffness in this population-based cohort was not independent of T2D and other metabolic risk factors. Our data suggest that a possible ...
African Trypanosomes have developed elaborate mechanisms to escape the adaptive immune response, but little is known about complement evasion particularly at the early stage of infection. Here we show...
Biological markers associated to post-COVID-19 condition (PCC) have not been clearly identified....
Eighty-two patients attending our post-COVID-19 outpatient clinic were recruited and classified as fully recovered (40.2%) or presenting with PCC (59.8%). Clinical and radiological data, laboratory ma...
Median number of days after hospitalization was 78.5 [p25-p75: 60-93] days. PCC was significantly more frequent in women, in patients with a previously critical COVID-19, and in those with two or more...
Patients with a post-COVID-19 condition showed significantly increased immunological parameters of inflammation (complement factor C3 and CD8 and Th1 T lymphocyte populations) compared to fully recove...
The aim is to evaluate the effect of a novel 14-day fasting regimen on the balance between skeletal muscle and adipose tissue composition which might associate with inflammatory factors. Our analysis ...
Eight healthy subjects were randomly selected from a pool of volunteers to undergo a continual dietary deprivation (CDD) regimen. Individuals were assigned to take Flexible Abrosia (FA, prebiotic comb...
The combination of FA and mineral supplements significantly decreased self-reported physical response of starvation, with tolerable hunger-mediated sensations experienced during CDD. Bioelectrical and...
Our results indicated that human subjects undergoing prolonged dietary restriction were well protected by FA and mineral ions from gut injury or physical discomfort of starvation. Most factors showed ...
We have attempted to explore further the involvement of complement components in the host COVID-19 (Coronavirus disease-19) immune responses by targeted genotyping of COVID-19 adult patients and analy...
Recently, it was shown that children at the onset of type 1 diabetes (T1D) have a higher proportion of oligomannose glycans in their total plasma protein N-glycome compared to their healthy siblings. ...
Patients with chronic hepatitis B (CHB) have a dynamic disease process and risk of end-stage liver disease. It is critical to unambiguously differentiate the stages of the disease and focus on therapy...
We retrospectively analyzed a wide range of CHB patients at different stages. The predictive power of serum complement component 3 (C3) levels for the development of acute-on-chronic liver failure (AC...
The decrease in serum C3 levels paralleled the severity of diseases related to hepatitis B virus. Patients with decompensated cirrhosis who developed ACLF had significantly lower serum C3 levels than ...
Serum C3 levels are valuable in assessing the severity of CHB-related stages. Low C3 levels signifies the development of ACLF in patients with decompensated cirrhosis....
A 62-year-old man with nephritic syndrome underwent a kidney biopsy which revealed a C3 dominant pattern on immunofluorescence. A diagnosis of C3 glomerulopathy (C3G) was suspected. However, a recent ...
C3 glomerulopathy (C3G) is a rare, progressive kidney disease resulting from dysregulation of the alternative pathway (AP) of complement. Biomarkers at baseline were investigated in patients with C3G ...
Patients with biopsy-confirmed C3G, proteinuria ≥500 mg/day, and estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2 were enrolled into two studies (NCT03369236 and NCT03459443). Biomarker ...
Twenty-nine patients were included in the analysis (median [interquartile range] age: 24.0 [10.0] years). Systemic complement AP activation was evident by reduced median concentrations of C3 and C5, e...
Associations among complement biomarkers, kidney function, and kidney histology may add to the current understanding of C3G and assist with the characterization of patients with this heterogenous dise...
Antibodies against Rho GDP-dissociation inhibitor 2 (RhoGDI2) are associated with inferior graft survival in transplant patients receiving a kidney from deceased donors. Although this suggests that th...